ResearchTrend.AI
  • Papers
  • Communities
  • Events
  • Blog
  • Pricing
Papers
Communities
Social Events
Terms and Conditions
Pricing
Parameter LabParameter LabTwitterGitHubLinkedInBlueskyYoutube

© 2025 ResearchTrend.AI, All rights reserved.

  1. Home
  2. Papers
  3. 2410.07890
51
0

Identifying latent disease factors differently expressed in patient subgroups using group factor analysis

10 October 2024
Fabio S. Ferreira
John Ashburner
Arabella Bouzigues
Chatrin Suksasilp
Lucy L. Russell
Phoebe H. Foster
Eve Ferry-Bolder
J. Swieten
L. Jiskoot
Harro Seelaar
Raquel Sanchez-Valle
Robert Laforce
Caroline Graff
Daniela Galimberti
Rik Vandenberghe
Alexandre de Mendonca
Pietro Tiraboschi
Isabel Santana
Alexander Gerhard
Johannes Levin
Shri Kiran Srinivasan
Markus Otto
Florence Pasquier
Simon Ducharme
Chris R. Butler
Isabelle Le Ber
Elizabeth Finger
Maria C. Tartaglia
Mario Masellis
James B. Rowe
Matthis Synofzik
Fermin Moreno
Barbara Borroni
Samuel Kaski
Jonathan D. Rohrer
J. Mourão-Miranda
    CML
ArXivPDFHTML
Abstract

In this study, we propose a novel approach to uncover subgroup-specific and subgroup-common latent factors addressing the challenges posed by the heterogeneity of neurological and mental disorders, which hinder disease understanding, treatment development, and outcome prediction. The proposed approach, sparse Group Factor Analysis (GFA) with regularised horseshoe priors, was implemented with probabilistic programming and can uncover associations (or latent factors) among multiple data modalities differentially expressed in sample subgroups. Synthetic data experiments showed the robustness of our sparse GFA by correctly inferring latent factors and model parameters. When applied to the Genetic Frontotemporal Dementia Initiative (GENFI) dataset, which comprises patients with frontotemporal dementia (FTD) with genetically defined subgroups, the sparse GFA identified latent disease factors differentially expressed across the subgroups, distinguishing between "subgroup-specific" latent factors within homogeneous groups and "subgroup common" latent factors shared across subgroups. The latent disease factors captured associations between brain structure and non-imaging variables (i.e., questionnaires assessing behaviour and disease severity) across the different genetic subgroups, offering insights into disease profiles. Importantly, two latent factors were more pronounced in the two more homogeneous FTD patient subgroups (progranulin (GRN) and microtubule-associated protein tau (MAPT) mutation), showcasing the method's ability to reveal subgroup-specific characteristics. These findings underscore the potential of sparse GFA for integrating multiple data modalities and identifying interpretable latent disease factors that can improve the characterization and stratification of patients with neurological and mental health disorders.

View on arXiv
Comments on this paper